HIV is an independent predictor of aortic stiffness

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Rider, Oliver J ^a,b   Asaad, Mina ^a,b   Ntusi, Ntobeko ^b   Wainwright, Emma ^a   Clutton, Genevieve ^a   Hancock, Gemma ^a   Banerjee, Rajarshi ^a   Pitcher, Alex ^b   Samaras, Katherine ^c   Clarke, Kieran ^a   Neubauer, Stefan ^a,b   Dorrell, Lucy ^a   Holloway, Cameron J ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Aorta; Cardiovascular magnetic resonance; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDEPENDENT VARIABLE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTOR VARIABLE; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENICITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; VIROLOGY;

ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; HIV INFECTIONS; HIV-1; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84906924485     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-014-0057-1     Document Type: Article

References (43)

1. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. JA Sterne, MA Hernan, B Ledergerber, K Tilling, R Weber, P Sendi, M Rickenbach, JM Robins, M Egger, Lancet 2005 366 378 384 10.1016/S0140-6736(05)67022-5 16054937
2. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. VA Triant, H Lee, C Hadigan, SK Grinspoon, J Clin Endocrinol Metab 2007 92 2506 2512 10.1210/jc.2006-2190 17456578
3. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. C Grunfeld, JAC Delaney, C Wanke, JS Currier, R Scherzer, ML Biggs, PC Tien, MG Shlipak, S Sidney, JF Polak, D O'Leary, P Bacchetti, RA Kronmal, SFRM Cha, AIDS 2009 23 1841 1849 10.1097/QAD.0b013e32832d3b85 19455012
4. Sudden cardiac death in patients with human immunodeficiency virus infection. ZH Tseng, EA Secemsky, D Dowdy, E Vittinghoff, B Moyers, JK Wong, DV Havlir, PY Hsue, J Am Coll Cardiol 2012 59 1891 1896 10.1016/j.jacc.2012.02.024 22595409
5. Impact of HIV infection and HAART on serum lipids in men. SA Riddler, E Smit, SR Cole, R Li, JS Chmiel, A Dobs, F Palella, B Visscher, R Evans, LA Kingsley, JAMA 2003 289 2978 2982 10.1001/jama.289.22.2978 12799406
6. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. SD Fisher, TL Miller, SE Lipshultz, Atherosclerosis 2006 185 1 11 10.1016/j.atherosclerosis.2005.09.025 16297390
7. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. PY Hsue, PW Hunt, A Schnell, SC Kalapus, R Hoh, P Ganz, JN Martin, SG Deeks, AIDS 2009 23 1059 1067 10.1097/QAD.0b013e32832b514b 19390417
8. Arterial inflammation in patients with HIV. S Subramanian, A Tawakol, TH Burdo, S Abbara, J Wei, J Vijayakumar, E Corsini, A Abdelbaky, MV Zanni, U Hoffmann, KC Williams, J Lo, SK Grinspoon, JAMA 2012 308 379 386 10.1001/jama.2012.6698 22820791
9. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. K Samaras, J Acquir Immune Defic Syndr 2009 50 499 505 10.1097/QAI.0b013e31819c291b 19223782
10. Small dense LDL and atherogenic lipid profile in HIV-positive adults: influence of lopinavir/ritonavir-containing regimen. S Badiou, CM De Boever, AM Dupuy, V Baillat, JP Cristol, J Reynes, AIDS 2003 17 772 774 10.1097/00002030-200303280-00023 12646808
11. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. CA Sabin, SW Worm, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, M Law, A D'Arminio Monforte, N Friis-Moller, O Kirk, C Pradier, I Weller, AN Phillips, JD Lundgren, Lancet 2008 371 1417 1426 10.1016/S0140-6736(08)60423-7 18387667
12. Combination antiretroviral therapy and the risk of myocardial infarction. N Friis-Moller, CA Sabin, R Weber, A d'Arminio Monforte, WM El-Sadr, P Reiss, R Thiebaut, L Morfeldt, S De Wit, C Pradier, G Calvo, MG Law, O Kirk, AN Phillips, JD Lundgren, N Engl J Med 2003 349 1993 2003 10.1056/NEJMoa030218 14627784
13. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? D Klein, LB Hurley, CP Quesenberry Jr, S Sidney, J Acquir Immune Defic Syndr 2002 30 471 477 10.1097/00126334-200208150-00002 12154337
14. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. K Sutton-Tyrrell, A Newman, EM Simonsick, R Havlik, M Pahor, E Lakatta, H Spurgeon, P Vaitkevicius, Hypertension 2001 38 429 433 10.1161/01.HYP.38.3.429 11566917
15. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. FU Mattace-Raso, TJ van der Cammen, A Hofman, NM van Popele, ML Bos, MA Schalekamp, R Asmar, RS Reneman, AP Hoeks, MM Breteler, JC Witteman, Circulation 2006 113 657 663 10.1161/CIRCULATIONAHA.105.555235 16461838
16. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. H Taniwaki, T Kawagishi, M Emoto, T Shoji, H Kanda, K Maekawa, Y Nishizawa, H Morii, Diabetes Care 1999 22 1851 1857 10.2337/diacare.22.11.1851 10546019
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143 3421
18. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews, JP Hosker, AS Rudenski, BA Naylor, DF Treacher, RC Turner, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825
19. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. F Wiesmann, SE Petersen, PM Leeson, JM Francis, MD Robson, Q Wang, R Choudhury, KM Channon, S Neubauer, J Am Coll Cardiol 2004 44 2056 2064 10.1016/j.jacc.2004.08.033 15542292
20. Increasing plasma free fatty acids in healthy subjects induces aortic distensibility changes seen in obesity. OJ Rider, CJ Holloway, Y Emmanuel, E Bloch, K Clarke, S Neubauer, Circ Cardiovasc Imaging 2012 5 367 375 10.1161/CIRCIMAGING.111.971804 22492484
21. Short-term exposure to exogenous lipids in premature infants and long-term changes in aortic and cardiac function. AJ Lewandowski, M Lazdam, E Davis, I Kylintireas, J Diesch, J Francis, S Neubauer, A Singhal, A Lucas, B Kelly, P Leeson, Arterioscler Thromb Vasc Biol 2011 31 2125 2135 10.1161/ATVBAHA.111.227298 21817105
22. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. OJ Rider, JM Francis, MK Ali, SE Petersen, M Robinson, MD Robson, JP Byrne, K Clarke, S Neubauer, J Am Coll Cardiol 2009 54 718 726 10.1016/j.jacc.2009.02.086 19679250
23. Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. CP Leeson, M Robinson, JM Francis, MD Robson, KM Channon, S Neubauer, F Wiesmann, J Cardiovasc Magn Reson 2006 8 381 387 10.1080/10976640500526993 16669182
24. The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging. OJ Rider, U Tayal, JM Francis, MK Ali, MR Robinson, JP Byrne, K Clarke, S Neubauer, Obesity 2010 18 2311 2316 10.1038/oby.2010.64 20360756
25. Rider OJ, Francis JM, Ali MK, Byrne J, Clarke K, Neubauer S, Petersen SE. Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2009; 11: 9.
26. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD, Group ISS. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008; 5: e203.
27. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. MECM Yasmin, S Wallace, IS Mackenzie, JR Cockcroft, IB Wilkinson, Arterioscler Thromb Vasc Biol 2004 24 969 974 10.1161/01.ATV.zhq0504.0173 15001456
28. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. K Tuomisto, P Jousilahti, J Sundvall, P Pajunen, V Salomaa, Thromb Haemost 2006 95 511 518 16525580
29. Mechanisms linking obesity with cardiovascular disease. LF Van Gaal, IL Mertens, CE De Block, Nature 2006 444 875 880 10.1038/nature05487 17167476
30. Inflammation and hypertension: the search for a link. P Pauletto, M Rattazzi, Nephrol Dial Transplant 2006 21 850 853 10.1093/ndt/gfl019 16464884
31. Primary endothelial dysfunction: atherosclerosis. H Shimokawa, J Mol Cell Cardiol 1999 31 23 37 10.1006/jmcc.1998.0841 10072713
32. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. JP van Wijk, EJ de Koning, MC Cabezas, J Joven, J op't Roodt, TJ Rabelink, AM Hoepelman, J Am Coll Cardiol 2006 47 1117 1123 10.1016/j.jacc.2005.09.073 16545639
33. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. IW Park, JF Wang, JE Groopman, Blood 2001 97 352 358 10.1182/blood.V97.2.352 11154208
34. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. C Zietz, B Hotz, M Sturzl, E Rauch, R Penning, U Lohrs, Am J Pathol 1996 149 1887 1898 8952525
35. Current update on HIV-associated vascular disease and endothelial dysfunction. H Mu, H Chai, PH Lin, Q Yao, C Chen, World J Surg 2007 31 632 643 10.1007/s00268-006-0730-0 17372667
36. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia. M Shahmanesh, S Das, M Stolinski, F Shojaee-Moradie, NC Jackson, W Jefferson, R Cramb, P Nightingale, AM Umpleby, J Clin Endocrinol Metab 2005 90 755 760 10.1210/jc.2004-1273 15522931
37. Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006; 4: e365.
38. Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy. MG van Vonderen, EA Hassink, MA van Agtmael, CD Stehouwer, SA Danner, P Reiss, Y Smulders, J Infect Dis 2009 199 1186 1194 10.1086/597475 19275490
39. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. K Wolf, DA Tsakiris, R Weber, P Erb, M Battegay, HIVCS Swiss, J Infect Dis 2002 185 456 462 10.1086/338572 11865397
40. Impact of metabolic syndrome on brachial-ankle pulse wave velocity in Japanese. A Tsubakimoto, I Saito, T Mannami, Y Naito, S Nakamura, Y Dohi, K Yonemasu, Hypertens Res 2006 29 29 37 10.1291/hypres.29.29 16715651
41. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. H Tomiyama, Y Koji, M Yambe, K Motobe, K Shiina, Z Gulnisa, Y Yamamoto, A Yamashina, Hypertension 2005 45 997 1003 10.1161/01.HYP.0000165018.63523.8a 15837828
42. The metabolic syndrome: more than the sum of its parts? MP Reilly, DJ Rader, Circulation 2003 108 1546 1551 10.1161/01.CIR.0000088846.10655.E0 14517150
43. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. FJ Torriani, L Komarow, RA Parker, BR Cotter, JS Currier, MP Dube, CJ Fichtenbaum, M Gerschenson, CK Mitchell, RL Murphy, K Squires, JH Stein, J Am Coll Cardiol 2008 52 569 576 10.1016/j.jacc.2008.04.049 18687253